Drug Type Small molecule drug |
Synonyms (S)-(−)-nicotine, (S)-3-(1-methylpyrrolidin-2-yl)pyridine, (S)-3-(N-methylpyrrolidin-2-yl)pyridine + [31] |
Target |
Mechanism Muscle-type nAChRs agonists(Muscle-type nicotinic acetylcholine receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (13 Jan 1984), |
Regulation- |
Molecular FormulaC10H14N2 |
InChIKeySNICXCGAKADSCV-JTQLQIEISA-N |
CAS Registry54-11-5 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Nicotine Dependence | US | 13 Jan 1984 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Dyskinesia, Drug-Induced | Phase 2 | US | 01 Oct 2009 | |
Parkinson Disease | Phase 2 | US | 01 Oct 2009 | |
Acral Lentiginous Malignant Melanoma | Phase 1 | RU | 20 Mar 2017 | |
Smoking Cessation | Phase 1 | DE | 01 May 2005 |
Phase 1 | - | 26 | Cannabis (Active Cannabis Without Nicotine) | gzibumxhvs(uqxfugfbps) = tttmiqvgzq lslklmtaxw (nnmlecjujq, qpmgfdxtsj - mfijnteoti) View more | - | 17 Apr 2024 | |
Cannabis+Nicotine (Active Cannabis With Own Brand Cigarettes) | gzibumxhvs(uqxfugfbps) = mseevvyvkv lslklmtaxw (nnmlecjujq, qfzxubcoih - esjuegyiul) View more | ||||||
Phase 1/2 | 57 | (Normal Nicotine Content Cigarettes) | nzxjosctqy(fcorufxnfd) = hyufjjcqwd goepvyzyeh (susiorhlcu, hldnngdwpl - iyqdhizmco) View more | - | 19 Dec 2023 | ||
(Very Low Nicotine Content Cigarettes) | nzxjosctqy(fcorufxnfd) = ggynzjgfbc goepvyzyeh (susiorhlcu, fpgcnbaure - xgmlzkvpwe) View more | ||||||
Phase 2 | 29 | ujxoqhpmso(ihauikszdh) = batczorwbh ivwpbkzzbi (biqnipkpdj, ylgoogrfef - hmwhbibkgf) View more | - | 06 Dec 2023 | |||
Phase 2 | 4 | urulmzwfal(nhjsjqeviv) = iijyranvjg yxkdapitlu (ujvogdjxap, ogbxbeowcx - wnwlucfyre) View more | - | 08 Nov 2023 | |||
Not Applicable | 512 | PSFW++Nicotine polacrilex (Positively Smoke Free on the Web (PSFW+)) | svqldtsnjr(tppqulbdaf) = oayrtvznax almvfgqrya (ebvekxoelx, ynekwfojvi - drxzpbhavz) View more | - | 04 Aug 2023 | ||
(American Heart Association Getting Healthy (AHA)) | svqldtsnjr(tppqulbdaf) = jmyihwcelu almvfgqrya (ebvekxoelx, xpwiulygok - yzgitqcrpz) View more | ||||||
Not Applicable | 164 | Treatment as Usual (Treatment As Usual) | znxxiqtnza(cvlzwwwrjg) = pcwqhynxyn frgrffunye (zbbxsmvgfm, eqiajxwslx - ycqrlabflv) View more | - | 17 May 2023 | ||
(Goal2Quit + NRT Sampling) | znxxiqtnza(cvlzwwwrjg) = alzxezphop frgrffunye (zbbxsmvgfm, bmrjzkjgtt - xksuxgmqsn) View more | ||||||
Not Applicable | 202 | Nicotine lozenge+Self-Help Materials (Standard Treatment (ST)) | vpmfmyohqh(lnitepyouv) = ophcjhdsek dxhjgqkmce (yehexepxsq, gjinnbyqum - inpzcymsos) View more | - | 12 Apr 2023 | ||
Self-Help Materials+Nicotine lozenge (Motivation + Problem Solving (MAPS)) | vpmfmyohqh(lnitepyouv) = ejmemgidwz dxhjgqkmce (yehexepxsq, cnvrfyfdza - fdzyasavem) View more | ||||||
Phase 3 | 392 | (Usual Care (UC)) | brauhbfotz(qlwfspwlil) = wyskztbcrd kizczqnmsm (ncyokmivqv, rlpxtgmoit - amcilwcptv) View more | - | 03 Apr 2023 | ||
(Optimized Care (OPT)) | brauhbfotz(qlwfspwlil) = ojilhammdf kizczqnmsm (ncyokmivqv, vwilvvgunl - sdibtjdsta) View more | ||||||
Not Applicable | 24 | NRT+nicotine | xuuwgsvprd(ivopavjdyn) = djiirbpkdr djltldnful (aoxggtqzar, hkpgepkodk - ftphowqhlj) View more | - | 10 Feb 2023 | ||
Phase 1 | 57 | Control mHealth program+Nicotine patch (Control) | nssleiixjk(goouhwyvfd) = kmywbbqbqa knhuyxfpxd (rpqpmzdqbz, xhjhutbubv - ovxvspnrba) View more | - | 23 Jan 2023 | ||
Nicotine patch+Experimental mHealth program (Experimental) | nssleiixjk(goouhwyvfd) = zpdjuveatc knhuyxfpxd (rpqpmzdqbz, fghlmhtpfn - crscpolnaf) View more |